Studies have also shown that hospitalized patients who have high levels of anti-toxin A IgG following CDI are less likely to develop diarrhea (50), and serum IgG and IgM responses to toxin A are crucial for protecting patients from CDI and preventing recurrence (51). This evidence concerns the gene CD40LG and clostridium difficile infection.